🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Hospital @ Home Model of Care for Cirrhosis

RecruitingNAAges 18 Years - anyAllIndiana University
NCT06396897 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to work with patients diagnosed with end-stage liver disease to understand their perspectives on the Health at Home (H@H) Program, including desired outcomes and expectations, perceived barriers, and drivers. H@H is an emerging model of home-based care, designed to extend traditional, inpatient hospital care which may address these needs. Through H@H, acute medical care services as well as ancillary care such as rehabilitation therapy can be delivered in the home. The study is divided into three phases: Phase 1 occurs while the participant is an inpatient. Phase 2 is when the actual H@H program takes place as part of the participant's clinical care. The study team will not be involved in the Phase 2 - H@H program as it will be conducted by the clinical staff. Phase 3, at which point the participant enters a rehabilitation phase to transition the patient to se

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Enrolled into IUH's H@H program * At least 18 years of age * Chronic liver disease/cirrhosis based on characteristic clinical, laboratory, and imaging findings * English speaking * Able to provide consent * Caregiver able to be present during the acute phase of care (first 48 hours post-hospital discharge) * Able to perform activities of daily living independently * Lives within IU Health Home service area Exclusion Criteria: * Unable to complete study questionnaires due to neurocognitive disease, legal blindness or hearing loss * Transplant of organ other than liver * Pregnant * Incarcerated * New hemodialysis * Blood pressure \< 90/60, Pulse \> 120, O2 \> 6L or \>2L above baseline * HIV+/CD4 count \< 200 * Receiving hospice services * Concurrent enrollment in a related research study
💊

What it tests

  • Indiana University Health Hospital at Home Program
📍

Where

1 site
IU School of Medicine
Indianapolis, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy